On March 21, 2016, Echo Therapeutics, Inc. issued a promissory note to Platinum Partners Value Arbitrage Fund L.P. (Lender") in the aggregate principal amount of $150,000 in respect of a bridge loan made by such party. The promissory note, which bears interest at the prime rate, may, at Lender's option, be exchanged for securities issued in a subsequent financing by the Company, including the second tranche financing described in the filing with the SEC on February 3, 2016.
Echo Therapeutics, Inc.
Equities
ECTE
US27876L2060
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+1.75% | 206B | |
+3.42% | 177B | |
+31.54% | 157B | |
+32.16% | 112B | |
+21.08% | 55.63B | |
-1.61% | 47.57B | |
-9.11% | 36.87B | |
-0.34% | 35.18B | |
+13.21% | 28.61B |